Huzi Xu
- Topics
- Acute Kidney Injury Research (3 papers)Chronic Kidney Disease and Diabetes (2 papers)Ferroptosis and cancer prognosis (2 papers)
- Partner nations
- ChinaSaudi Arabia
In The Last Decade
Huzi Xu
16 papers receiving 471 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 278
- Pulmonary and Respiratory Medicine 170
- Cancer Research 135
- Nephrology 90
- Surgery 44
Countries citing papers authored by Huzi Xu
This map shows the geographic impact of Huzi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huzi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huzi Xu more than expected).
Fields of papers citing papers by Huzi Xu
This network shows the impact of papers produced by Huzi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huzi Xu. The network helps show where Huzi Xu may publish in the future.
Co-authorship network of co-authors of Huzi Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Huzi Xu. A scholar is included among the top collaborators of Huzi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huzi Xu. Huzi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 19 | |
| 3 | 2 | |
| 4 | 10 | |
| 5 | 30 | |
| 6 | 4 | |
| 7 | 28 | |
| 8 | Combination of ultra-low dose rituximab and low dose tacrolimus versus tacrolimus alone in the treatment of non-responsive idiopathic membranous nephropathy: a Chinese retrospective cohort study. | 6 |
| 9 | 179 | |
| 10 | 20 | |
| 11 | 3 | |
| 12 | 28 | |
| 13 | GAG and collagen II attenuate glucocorticoid-induced osteoporosis by regulating NF-κB and MAPK signaling. | 6 |
| 14 | Evaluation of the safety and tolerability of tamoxifen for ischemia-incited renal injury in mice. | 2 |
| 15 | Melatonin promoted renal regeneration in folic acid-induced acute kidney injury via inhibiting nucleocytoplasmic translocation of HMGB1 in tubular epithelial cells. | 29 |
| 16 | 106 |
About Huzi Xu
Huzi Xu is a scholar working on Nephrology, Clinical Biochemistry and Developmental Neuroscience, having authored 16 papers that have together received 473 indexed citations. Recurring topics across this work include Acute Kidney Injury Research (3 papers), Chronic Kidney Disease and Diabetes (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Nephrology (90 citations), Cancer Research (135 citations) and Pulmonary and Respiratory Medicine (170 citations). Huzi Xu has collaborated with scholars based in China and Saudi Arabia. Frequent co-authors include Ying Yao, Rui Zeng, Zhi Zhao, Han Zhu, Gang Xu, Zhizhi Hu, Jianliang Wu, Cheng Zhou, Zhangyin Ming and Yuxi Wang. Their work appears in journals such as Nature Communications, Frontiers in Microbiology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.